Citation Impact
Citing Papers
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
2017 Standout
Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice
1990
Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma*
1991
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats
2009
Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response
1996
Clinical Update on Pentoxifylline Therapy for Diabetes-Induced Peripheral Vascular Disease
1993
An Evaluation of the Biological and Toxicological Properties ofAloe Barbadensis(Miller), Aloe Vera
2006 Standout
ACETAMINOPHEN-INDUCED HEPATOTOXICITY
2003 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Pentoxifylline for Renoprotection in Diabetic Nephropathy: the PREDIAN study. Rationale and basal results
2010
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
2001 StandoutNobel
The genotoxicity of industrial wastes and effluents
1992 Standout
Multi‐organellar disorders of pigmentation: tied up in traffic
1999
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks
2012
Does Effective Management of Sleep Disorders Reduce Depressive Symptoms and the Risk of Depression?
2009
Diversification of Catalytic Function in a Synthetic Family of Chimeric Cytochrome P450s
2007 StandoutNobel
Epidemiology and risk factors for IBD
2015 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
1990 Standout
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Inflammatory Bowel Disease
1991 Standout
Lethality and hepatotoxicity of complex waste mixtures
1988
Kinetics and Dynamics of Prednisolone*
1987
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Time, self and the medication day: a closer look at the everyday work of ‘adherence’
2009 Standout
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
2004 Standout
Association of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use
1994
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Acetaminophen‐induced acute liver failure
2005 Standout
Erythromycin Suppresses Nuclear Factor-κB and Activator Protein-1 Activation in Human Bronchial Epithelial Cells
2000 StandoutNobel
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Human drug metabolism in vitro
1988
Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4
1993
Comorbidity of insomnia and depression
2009
Inflammatory Bowel Disease
2001
Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures
1993 Standout
Enzyme induction in the cytochrome P-450 system
1990 Standout
Herb-Drug Interactions
2005 Standout
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Role of antioxidants in paraquat toxicity
2002 Standout
Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
2011 Standout
Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005
2005 Standout
Influences of roxithromycin on cell-mediated immune responses
1992
Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice
2015 StandoutNobel
Inhibition and induction of human cytochrome P450 (CYP) enzymes
1998
Biology of hypopigmentation
1988
Infection in Organ-Transplant Recipients
1998 Standout
The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature
1993 Standout
The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice
1987
Robbins and Cotran Pathologic Basis of Disease
2020 Standout
Host-Bacterial Mutualism in the Human Intestine
2005 StandoutScience
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
The Indications for Polysomnography and Related Procedures
1997
Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites.
1998
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene.
1992
Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.
1993
Medications as Social Phenomena
2001
W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
1995 StandoutNature
Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
1996
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
Cytochrome P-450 and halothane metabolism. Decrease in rat liver microsomal P-450 in vitro
1983
Johne's Disease, Inflammatory Bowel Disease, andMycobacterium paratuberculosis
2004
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450
1991
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
The Treatment of Acetaminophen Poisoning
1983
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Mechanisms of Diabetic Complications
2013 Standout
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002 Standout
Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.
1987 StandoutNobel
A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2.
1995
Problems in Assessing the Risks of Mixtures of Contaminants in Drinking Water
1989
Identification of an inducible form of cytochrome P-450 in human liver.
1985
Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p
1985
Recent Developments in Nonspecific Inflammatory Bowel Disease
1982
Chlorinated Methanes and Liver Injury: Highlights of the Past 50 Years
2000
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Protection against paraquat-induced injury by exogenous GSH in pulmonary alveolar type II cells
1986
Human cytochromes P-450
1984
Works of Barton Cobert being referenced
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
1983
Effects on Sleep: A Double-Blind Study Comparing Trimipramine to Imipramine in Depressed Insomniac Patients
1989
The Internet and Drug Safety
1999
Dose-response effects of pentoxifylline on erythrocyte filterability: Clinical and animal model studies
1990
Additive effects of inducers and fasting on acetaminophen hepatotoxicity
1980
Hepatotoxicity of Trichloroethylene-Carbon Tetrachloride Mixtures in Rats
1982
Hypo activity of cytochrome P-450 after triacetyloleandomycin administration
1981
Hermansky-Pudlak Syndrome with Granulomatous Colitis
1980
Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450
1981
Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication
1989